Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

NCT06848426 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer Recurrent
Non-small Cell Lung Cancer Stage IIIB
Non-small Cell Lung Cancer Stage IV
Non-small Cell Lung Cancer Metastatic

Interventions

DRUG: Xingbaiji Formula

Sponsor

Jiangxi Provincial People's Hopital